DGAP-News: MorphoSys AG Reports Second Quarter and First Hal

DGAP-News: MorphoSys AG / Key word(s): Half Year Results MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results ...

Related Keywords

Germany , United States , United Kingdom , Planegg , Bayern , Massachusetts , Boston , China , South Korea , Canada , Kaitlyn Nealy , Thomas Biegi , Julia Neugebauer , Jean Paul Kress , Myles Clouston , Janssen Biotech Inc , Xencor Inc , Linkedin , Twitter , Drug Administration , European Hematology Association , Nasdaq , Exchange Commission , Pfizer , Morphosys Group Key Figures , Development Rd Expenses , Human Immunology Biosciences Inc , Second Quarter , First Half , Fusion Protein Directed Against , Chief Executive Officer , Human Immunology Biosciences , Greater China , Events After , Royalty Pharma , Net Loss , Net Profit , Full Year , Sys Group Key Figures , Impairment Losses , Tax Benefit , Antibody Dependent Cell Mediated Cytotoxicity , Antibody Dependent Cellular Phagocytosis , Janssen Biotech , Morphosy Annual Report ,